Sichuan Shuangma Cement Co Ltd - Asset Resilience Ratio
Sichuan Shuangma Cement Co Ltd (000935) has an Asset Resilience Ratio of 1.72% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000935 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Sichuan Shuangma Cement Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Sichuan Shuangma Cement Co Ltd total assets.
Liquid Assets Composition Over Time
This chart breaks down Sichuan Shuangma Cement Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 000935 liabilities breakdown for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥168.37 Million | 1.72% |
| Total Liquid Assets | CN¥168.37 Million | 1.72% |
Asset Resilience Insights
- Limited Liquidity: Sichuan Shuangma Cement Co Ltd maintains only 1.72% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sichuan Shuangma Cement Co Ltd Industry Peers by Asset Resilience Ratio
Compare Sichuan Shuangma Cement Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Senvest Capital Inc.
TO:SEC |
Asset Management | 1.75% |
|
Nuveen Multi-Asset Income Fund
NYSE:NMAI |
Asset Management | 0.09% |
|
Sprott Physical Silver
TO:PSLV |
Asset Management | 99.90% |
|
Janus Henderson Group PLC
F:HDJA |
Asset Management | 18.51% |
|
Compagnie du Cambodge
PA:CBDG |
Asset Management | 0.00% |
|
Central Securities Corporation
NYSE MKT:CET |
Asset Management | 3.19% |
|
A.F.P. Habitat
SN:HABITAT |
Asset Management | 7.59% |
|
UTI Asset Management Company Limited
NSE:UTIAMC |
Asset Management | 8.10% |
Annual Asset Resilience Ratio for Sichuan Shuangma Cement Co Ltd (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Sichuan Shuangma Cement Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.81% | CN¥79.01 Million ≈ $11.56 Million |
CN¥9.73 Billion ≈ $1.42 Billion |
+0.70pp |
| 2024-12-31 | 0.11% | CN¥10.00 Million ≈ $1.46 Million |
CN¥8.99 Billion ≈ $1.32 Billion |
-9.85pp |
| 2023-12-31 | 9.96% | CN¥816.33 Million ≈ $119.46 Million |
CN¥8.19 Billion ≈ $1.20 Billion |
+8.57pp |
| 2022-12-31 | 1.40% | CN¥100.60 Million ≈ $14.72 Million |
CN¥7.21 Billion ≈ $1.06 Billion |
-5.56pp |
| 2021-12-31 | 6.96% | CN¥451.45 Million ≈ $66.06 Million |
CN¥6.49 Billion ≈ $949.75 Million |
+5.69pp |
| 2020-12-31 | 1.27% | CN¥70.16 Million ≈ $10.27 Million |
CN¥5.53 Billion ≈ $809.46 Million |
-1.43pp |
| 2019-12-31 | 2.70% | CN¥131.10 Million ≈ $19.18 Million |
CN¥4.85 Billion ≈ $710.17 Million |
-5.48pp |
| 2018-12-31 | 8.18% | CN¥341.12 Million ≈ $49.92 Million |
CN¥4.17 Billion ≈ $610.07 Million |
+7.96pp |
| 2017-12-31 | 0.22% | CN¥13.63 Million ≈ $1.99 Million |
CN¥6.11 Billion ≈ $893.54 Million |
-- |
About Sichuan Shuangma Cement Co Ltd
Sichuan Hexie Shuangma Co., Ltd. engages in the manufacture and sale building material products in China. It offers cement, commercial clinker, and aggregates used for infrastructure, industrial park construction, municipal livelihood projects, commercial housing development, urban renewal, and rural revitalization. The company is also involved in biopharmaceutical research and development and pr… Read more